Clinical Trials Logo

Clinical Trial Summary

- To determine the mass balance of totalradioactivity following a single IV infusionof (14C)-OPC-61815. - To determine routes and rates of elimination of total radioactivity following a single IV infusion of (14C)-OPC-61815 - To assess the PK of total radioactivity in plasma and whole blood following a single IV infusion of (14C)-OPC-61815 - To assess the PK of OPC-61815 free form and OPC-41061 in plasma following a single IV infusion of (14C)-OPC-61815


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04182958
Study type Interventional
Source Otsuka Pharmaceutical Co., Ltd.
Contact
Status Completed
Phase Phase 1
Start date November 25, 2019
Completion date December 19, 2019

See also
  Status Clinical Trial Phase
Completed NCT02875080 - Evaluation Study of the Bioavailability of Brexpiprazole Orally Disintegrating Tablets in Healthy Male Subjects Phase 1
Completed NCT03902574 - Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mg Phase 1
Completed NCT05439148 - OPC-61815 in Healthy Chinese Male Subjects Phase 1
Completed NCT02994394 - A Study of OPC-41061 Orally Disintegrating (OD) Tablets Using 2 Different Formulations and 2 Dosing Regimens in Healthy Adult Male Subjects Phase 1
Completed NCT04415645 - Absorption, Metabolism, Excretion, and Mass Balance Study of [14C]-VVZ-149 in Healthy Adult Male Subjects Phase 1
Completed NCT01423435 - Study to Compare Pharmacokinetic Profiles of TRK-100STP in Japanese, Chinese, and South Korean Non-elderly Healthy Adult Males Phase 1
Completed NCT01258699 - A Study Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjects Phase 1